Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Thirty-Day Hospital Readmission and Surgical Complication Rates for Shunting in Normal Pressure Hydrocephalus: A Large National Database Analysis.

Nadel JL, Wilkinson DA, Linzey JR, Maher CO, Kotagal V, Heth JA.

Neurosurgery. 2019 Aug 16. pii: nyz299. doi: 10.1093/neuros/nyz299. [Epub ahead of print]

PMID:
31420654
2.

Fatigue in Parkinson's Disease Associates with Lower Ambulatory Diastolic Blood Pressure.

Kotagal V, Szpara A, Albin RL, Bohnen NI.

J Parkinsons Dis. 2019;9(3):575-581. doi: 10.3233/JPD-191579.

3.

The 10-year Landscape of United States-Registered Parkinson Disease Clinical Trials: 2007-2016.

Wyant KJ, Yasuda E, Kotagal V.

Mov Disord Clin Pract. 2018 Oct 4;5(5):512-518. doi: 10.1002/mdc3.12665. eCollection 2018 Sep-Oct.

PMID:
30515440
4.

Serious adverse events following Normal Pressure Hydrocephalus surgery.

Kotagal V, Walkowiak E, Heth JA.

Clin Neurol Neurosurg. 2018 Jul;170:113-115. doi: 10.1016/j.clineuro.2018.05.008. Epub 2018 May 15.

PMID:
29772402
5.

Serotonin, β-amyloid, and cognition in Parkinson disease.

Kotagal V, Spino C, Bohnen NI, Koeppe R, Albin RL.

Ann Neurol. 2018 May;83(5):994-1002. doi: 10.1002/ana.25236. Epub 2018 May 11.

6.

Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease.

Kotagal V, Albin RL, Müller MLTM, Bohnen NI.

J Parkinsons Dis. 2018;8(1):153-160. doi: 10.3233/JPD-171271.

7.

Color discrimination errors associate with axial motor impairments in Parkinson's disease.

Bohnen NI, Haugen J, Ridder A, Kotagal V, Albin RL, Frey KA, Müller MLTM.

Mov Disord Clin Pract. 2017 Nov-Dec;4(6):864-869. doi: 10.1002/mdc3.12527. Epub 2017 Sep 8.

8.

Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease.

Kotagal V, Bohnen NI, Müller ML, Frey KA, Albin RL.

J Parkinsons Dis. 2017;7(1):143-147. doi: 10.3233/JPD-160985.

9.

Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT Study.

Bohnen NI, Haugen J, Kluin K, Kotagal V.

Case Rep Neurol Med. 2016;2016:8941035. doi: 10.1155/2016/8941035. Epub 2016 Nov 24.

10.

Orthostatic hypotension predicts motor decline in early Parkinson disease.

Kotagal V, Lineback C, Bohnen NI, Albin RL; CALM-PD Parkinson Study Group Investigators.

Parkinsonism Relat Disord. 2016 Nov;32:127-129. doi: 10.1016/j.parkreldis.2016.09.011. Epub 2016 Sep 9.

11.

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.

Ridder A, Müller ML, Kotagal V, Frey KA, Albin RL, Bohnen NI.

Parkinsonism Relat Disord. 2017 Jan;34:15-19. doi: 10.1016/j.parkreldis.2016.10.006. Epub 2016 Oct 7.

12.

Is PIGD a legitimate motor subtype in Parkinson disease?

Kotagal V.

Ann Clin Transl Neurol. 2016 May 11;3(6):473-7. doi: 10.1002/acn3.312. eCollection 2016 Jun.

13.

Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation.

Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI.

J Neural Transm (Vienna). 2016 Apr;123(4):421-4. doi: 10.1007/s00702-016-1524-7. Epub 2016 Feb 24.

14.

Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.

Petrou M, Davatzikos C, Hsieh M, Foerster BR, Albin RL, Kotagal V, Müller ML, Koeppe RA, Herman WH, Frey KA, Bohnen NI.

Acad Radiol. 2016 May;23(5):577-81. doi: 10.1016/j.acra.2015.07.014. Epub 2016 Feb 10.

15.

Neuroimaging and clinical predictors of fatigue in Parkinson disease.

Chou KL, Kotagal V, Bohnen NI.

Parkinsonism Relat Disord. 2016 Feb;23:45-9. doi: 10.1016/j.parkreldis.2015.11.029. Epub 2015 Dec 2.

16.

Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.

Shah N, Frey KA, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI.

Mov Disord. 2016 Jan;31(1):111-7. doi: 10.1002/mds.26369. Epub 2015 Sep 18.

17.

Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration.

Snider J, Müller ML, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Albin RL, Bohnen NI.

Parkinsonism Relat Disord. 2015 Oct;21(10):1227-31. doi: 10.1016/j.parkreldis.2015.08.027. Epub 2015 Aug 28.

18.

Educational attainment and motor burden in Parkinson's disease.

Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Langa KM, Albin RL.

Mov Disord. 2015 Jul;30(8):1143-7. doi: 10.1002/mds.26272. Epub 2015 Jun 10.

19.

Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.

Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA.

JAMA Neurol. 2015 Feb;72(2):194-200. doi: 10.1001/jamaneurol.2014.2757.

20.

Validity and Efficacy of Screening Algorithms for Assessing Deep Brain Stimulation Candidacy in Parkinson Disease.

Coleman RR, Kotagal V, Patil PG, Chou KL.

Mov Disord Clin Pract. 2014 Dec 1;1(4):342-347.

21.

Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage.

Fletcher JJ, Kotagal V, Mammoser A, Peterson M, Morgenstern LB, Burke JF.

Stroke. 2015 Jan;46(1):58-64. doi: 10.1161/STROKEAHA.114.006653. Epub 2014 Dec 4.

22.

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.

Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M.

Parkinsonism Relat Disord. 2014 Dec;20(12):1394-8. doi: 10.1016/j.parkreldis.2014.10.008. Epub 2014 Oct 15.

23.

Factors associated with cognitive evaluations in the United States.

Kotagal V, Langa KM, Plassman BL, Fisher GG, Giordani BJ, Wallace RB, Burke JR, Steffens DC, Kabeto M, Albin RL, Foster NL.

Neurology. 2015 Jan 6;84(1):64-71. doi: 10.1212/WNL.0000000000001096. Epub 2014 Nov 26.

24.

Clinical markers for identifying cholinergic deficits in Parkinson's disease.

Müller ML, Bohnen NI, Kotagal V, Scott PJ, Koeppe RA, Frey KA, Albin RL.

Mov Disord. 2015 Feb;30(2):269-73. doi: 10.1002/mds.26061. Epub 2014 Nov 12.

25.

Author response.

Bohnen NI, Kotagal V, Albin R, Muller M.

Neurology. 2014 Jul 1;83(1):103. No abstract available.

PMID:
25110786
26.

Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.

Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML.

Mov Disord. 2014 Aug;29(9):1118-24. doi: 10.1002/mds.25929. Epub 2014 Jun 7.

27.

Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Studenski S, Frey KA, Bohnen NI.

J Gerontol A Biol Sci Med Sci. 2014 Dec;69(12):1569-75. doi: 10.1093/gerona/glu070. Epub 2014 May 26.

28.

Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI.

Neurology. 2014 Apr 29;82(17):1514-20. doi: 10.1212/WNL.0000000000000356. Epub 2014 Mar 28.

29.

Gait speed in Parkinson disease correlates with cholinergic degeneration.

Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML.

Neurology. 2013 Oct 29;81(18):1611-6. doi: 10.1212/WNL.0b013e3182a9f558. Epub 2013 Sep 27.

30.

Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.

Weathers SP, Kotagal V, Bohnen NI, Chou KL.

Parkinsonism Relat Disord. 2014 Jan;20(1):13-6. doi: 10.1016/j.parkreldis.2013.08.021. Epub 2013 Sep 8.

31.

Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.

Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI.

Brain. 2013 Nov;136(Pt 11):3282-9. doi: 10.1093/brain/awt247. Epub 2013 Sep 20.

32.

Acetazolamide-responsive ataxia.

Kotagal V.

Semin Neurol. 2012 Nov;32(5):533-7. doi: 10.1055/s-0033-1334475. Epub 2013 May 15. Review.

PMID:
23677664
33.

Gender differences in cholinergic and dopaminergic deficits in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI.

J Neural Transm (Vienna). 2013 Oct;120(10):1421-4. doi: 10.1007/s00702-013-1013-1. Epub 2013 Mar 27.

34.

Diabetes is associated with postural instability and gait difficulty in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI.

Parkinsonism Relat Disord. 2013 May;19(5):522-6. doi: 10.1016/j.parkreldis.2013.01.016. Epub 2013 Feb 23.

35.

Clinical features of Parkinson disease when onset of diabetes came first: a case-control study.

Kotagal V, Albin RL, Müller ML, Bohnen NI.

Neurology. 2012 Oct 23;79(17):1835-6; author reply 1836. No abstract available.

PMID:
23251922
36.

β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.

Müller ML, Frey KA, Petrou M, Kotagal V, Koeppe RA, Albin RL, Bohnen NI.

Mov Disord. 2013 Mar;28(3):296-301. doi: 10.1002/mds.25213. Epub 2012 Dec 12.

37.

Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease.

Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Albin RL.

Arch Neurol. 2012 Dec;69(12):1628-31. doi: 10.1001/archneurol.2012.764.

38.

A frontotemporal dementia-like syndrome mimicking postpartum depression detected by 18F fluorodeoxyglucose positron emission tomography.

Kotagal V, Lorincz MT, Bohnen NI.

Clin Nucl Med. 2012 Sep;37(9):e223-4. doi: 10.1097/RLU.0b013e31824440a1.

PMID:
22889797
39.

An update on brain imaging in parkinsonian dementia.

Petrou M, Kotagal V, Bohnen NI.

Imaging Med. 2012 Apr;4(2):201-213.

40.

Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1609-17. doi: 10.1038/jcbfm.2012.60. Epub 2012 May 9.

41.

Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI.

Ann Neurol. 2012 Apr;71(4):560-8. doi: 10.1002/ana.22691.

42.

Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.

Kotagal V, Müller ML, Kaufer DI, Koeppe RA, Bohnen NI.

Neurosci Lett. 2012 Apr 18;514(2):169-72. doi: 10.1016/j.neulet.2012.02.083. Epub 2012 Mar 3.

43.

Motor improvement with bilateral subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive secondary parkinsonism.

Kotagal V, Patil PG, Chou KL.

Parkinsonism Relat Disord. 2012 Jan;18(1):79-81. doi: 10.1016/j.parkreldis.2011.08.014. Epub 2011 Sep 7.

PMID:
21903443
44.

A 26-year-old woman with recurrent loss of consciousness.

Benson MR, Kotagal V, Oral H.

J Gen Intern Med. 2011 Dec;26(12):1507-12. doi: 10.1007/s11606-011-1784-8. Epub 2011 Jul 8.

45.

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA.

Brain. 2010 Jun;133(Pt 6):1747-54. doi: 10.1093/brain/awq079. Epub 2010 Apr 22.

46.

[18F]FDOPA PET and clinical features in parkinsonism due to manganism.

Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS.

Mov Disord. 2005 Apr;20(4):492-6.

PMID:
15648057
47.

Pathophysiology of parkinsonism due to hydrocephalus.

Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS.

J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1617-9.

Supplemental Content

Loading ...
Support Center